The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020
- PMID: 33382671
- PMCID: PMC9191902
- DOI: 10.15585/mmwr.mm695152e2
The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020
Abstract
The first vaccines for prevention of coronavirus disease 2019 (COVID-19) in the United States were authorized for emergency use by the Food and Drug Administration (FDA) (1) and recommended by the Advisory Committee on Immunization Practices (ACIP) in December 2020.* However, demand for COVID-19 vaccines is expected to exceed supply during the first months of the national COVID-19 vaccination program. ACIP advises CDC on population groups and circumstances for vaccine use.† On December 1, ACIP recommended that 1) health care personnel§ and 2) residents of long-term care facilities¶ be offered COVID-19 vaccination first, in Phase 1a of the vaccination program (2). On December 20, 2020, ACIP recommended that in Phase 1b, vaccine should be offered to persons aged ≥75 years and frontline essential workers (non-health care workers), and that in Phase 1c, persons aged 65-74 years, persons aged 16-64 years with high-risk medical conditions, and essential workers not recommended for vaccination in Phase 1b should be offered vaccine.** These recommendations for phased allocation provide guidance for federal, state, and local jurisdictions while vaccine supply is limited. In its deliberations, ACIP considered scientific evidence regarding COVID-19 epidemiology, ethical principles, and vaccination program implementation considerations. ACIP's recommendations for COVID-19 vaccine allocation are interim and might be updated based on changes in conditions of FDA Emergency Use Authorization, FDA authorization for new COVID-19 vaccines, changes in vaccine supply, or changes in COVID-19 epidemiology.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Similar articles
-
The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1857-1859. doi: 10.15585/mmwr.mm6949e1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33301429 Free PMC article.
-
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.MMWR Morb Mortal Wkly Rep. 2021 Jan 1;69(5152):1653-1656. doi: 10.15585/mmwr.mm695152e1. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33382675 Free PMC article.
-
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1344-1348. doi: 10.15585/mmwr.mm7038e2. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34555007 Free PMC article.
-
Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC).Vaccine. 2011 Nov 15;29(49):9171-6. doi: 10.1016/j.vaccine.2011.08.005. Epub 2011 Aug 11. Vaccine. 2011. PMID: 21839794 Review.
-
Principles of Vaccine Licensure, Approval, and Recommendations for Use.Mayo Clin Proc. 2020 Mar;95(3):600-608. doi: 10.1016/j.mayocp.2019.11.002. Epub 2020 Feb 13. Mayo Clin Proc. 2020. PMID: 32063358 Review.
Cited by
-
Assessing the Impact of COVID-19 Vaccination Programs on the Reduction of COVID-19 Cases: A Systematic Literature Review.Ann Glob Health. 2024 Jul 22;90(1):45. doi: 10.5334/aogh.4484. eCollection 2024. Ann Glob Health. 2024. PMID: 39070079 Free PMC article.
-
Investigating the trend of demographic changes, mortality, clinical and paraclinical findings of patients hospitalized in the Corona ward, before and after the start of general vaccination of COVID-19.BMC Infect Dis. 2024 May 13;24(1):488. doi: 10.1186/s12879-024-09279-z. BMC Infect Dis. 2024. PMID: 38741059 Free PMC article.
-
COVID-19 Vaccine Uptake and Attitudes Within Two Cohorts of Younger Adult Cannabis Users.J Drug Issues. 2023 Jul;53(3):422-430. doi: 10.1177/00220426221131488. Epub 2022 Oct 2. J Drug Issues. 2023. PMID: 38603185 Free PMC article.
-
Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022.MMWR Morb Mortal Wkly Rep. 2024 Apr 11;73(14):317-320. doi: 10.15585/mmwr.mm7314a5. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38602888 Free PMC article.
-
Nucleic acid-based drugs for patients with solid tumours.Nat Rev Clin Oncol. 2024 Jun;21(6):407-427. doi: 10.1038/s41571-024-00883-1. Epub 2024 Apr 8. Nat Rev Clin Oncol. 2024. PMID: 38589512 Review.
References
-
- Food and Drug Administration. COVID-19 vaccines. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2020. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-dise...
-
- Cybersecurity and Infrastructure Security Agency. Guidance on essential critical infrastructure workers: version 4.0. Washington, DC: US Department of Homeland Security, Cybersecurity and Infrastructure Security Agency; 2020. https://www.cisa.gov/publication/guidance-essential-critical-infrastruct...
-
- National Academies of Sciences, Engineering, and Medicine. Framework for equitable allocation of COVID-19 vaccine. Washington, DC: National Academies of Sciences, Engineering, and Medicine; 2020. https://www.nationalacademies.org/our-work/a-framework-for-equitable-all... - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical